Association of Behçet’s disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis

The present meta-analysis aimed to elucidate the association of Behçet’s disease (BD) with the risk of metabolic syndrome (MetS) and its components. Observational cohort studies were searched from the Embase, Web of Science, Medline, and Cochrane Library databases. The primary outcome was the associ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental medicine Jg. 23; H. 6; S. 2855 - 2866
Hauptverfasser: Chen, Tingqiao, Shao, Xinyi, Li, Hao, Chen, Yangmei, Liu, Lin, Zhong, Judan, Chen, Jin
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Cham Springer International Publishing 01.10.2023
Springer Nature B.V
Schlagworte:
Behcet's syndrome
Blood levels
Blood pressure
Clinical Practice
Cohort analysis
Comorbidity
Diabetes mellitus
Dyslipidemia
Glucose
Hematology
Hypertension
Inflammatory diseases
Internal Medicine
Medicine
Medicine & Public Health
Meta-analysis
Metabolic disorders
Metabolic syndrome
Mortality
Obesity
Observational studies
Oncology
Sensitivity analysis
Systematic review
Vein & artery diseases
Hypertension
Behçet’s disease
Metabolic syndrome
Diabetes mellitus
Dyslipidemia
Meta-analysis
ISSN:1591-9528, 1591-8890, 1591-9528
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present meta-analysis aimed to elucidate the association of Behçet’s disease (BD) with the risk of metabolic syndrome (MetS) and its components. Observational cohort studies were searched from the Embase, Web of Science, Medline, and Cochrane Library databases. The primary outcome was the association of BD with the risk of MetS and its relevant components. Effect estimates with odds ratios (ORs) were pooled using either the random-effects or fixed-effects models, according to heterogeneity. Leave-one-out sensitivity analyses were used to determine the stability of the results. Twenty-three studies, comprising 42,834 patients with BD, were included. Overall, a significant association between BD and the risk of MetS was found (pooled OR 2.26; 95% confidence interval [CI] 1.61–3.17; P  < 0.0001). Among the components of MetS, significant associations were found between BD and diabetes mellitus (OR 1.21; 95% CI 1.10–1.33; P  < 0.0001), BD and hypertension (OR 1.39; 95% CI 1.13–1.70; P  = 0.002), and BD and dyslipidemia (OR 1.21; 95% CI 1.01–1.45; P  = 0.04). Our study indicated an association between BD and the risk of MetS and some of its components (diabetes mellitus, hypertension, and dyslipidemia). Physician should consider these associations so that specific treatments are available for patients with comorbidities. Moreover, patients with BD should regularly monitor their blood pressure, fasting plasma glucose, and blood lipid levels.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:1591-9528
1591-8890
1591-9528
DOI:10.1007/s10238-023-01044-x